Patent directory · USPTO A61K / A61P
Patents matching “Northwest Biotherapeutics, Inc.”
10 pharma patents match "Northwest Biotherapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 10 pharmaceutical patents matching "Northwest Biotherapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11124768
Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response
granted -
US 9566294
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
granted -
US 8518636
Tangential flow filtration devices and methods for leukocyte enrichment
granted -
US 8409566
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
granted -
US 7790039
Tangential flow filtration devices and methods for stem cell enrichment
granted -
US 7695627
Tangential flow filtration devices and methods for leukocyte enrichment
granted -
US 7087715
Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
granted -
US 6936448
Nucleic acids and proteins of a rat ganglioside GM1-specific α1-2fucosyltransferase and uses thereof
expired -
US 6863887
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
expired -
US 6150508
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
expired